KBC Group
VERA icon

KBC Group’s Vera Therapeutics VERA Stock Holding History

KBC Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Hold
1,282
– – ﹤0.01% 1679
2026
Q1 		$52K Sell
1,282
-670
-34% -$28.9K ﹤0.01% 1637
2025
Q4 		$99K Hold
1,952
– – ﹤0.01% 1290
2025
Q3 		$57K Buy
1,952
+1,250
+178% +$28.9K ﹤0.01% 1605
2025
Q2 		$17K Sell
702
-1,775
-72% -$39.9K ﹤0.01% 1709
2025
Q1 		$59K Hold
2,477
– – ﹤0.01% 1740
2024
Q4 		$105K Buy
2,477
+1,387
+127% +$61.4K ﹤0.01% 1525
2024
Q3 		$48K Hold
1,090
– – ﹤0.01% 1731
2024
Q2 		$39K Hold
1,090
– – ﹤0.01% 1742
2024
Q1 		$47K Buy
+1,090
New +$38.8K ﹤0.01% 1600

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KBC Group's VERA Position: Q2 2026 in Review

KBC Group held its Vera Therapeutics (VERA) position steady in Q2 2026 at 1,282 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

KBC Group first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $105K in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • KBC Group held 1,282 shares of Vera Therapeutics worth $55K as of Q2 2026.
  • KBC Group left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1679 holding.
  • KBC Group first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • KBC Group's Vera Therapeutics position peaked at $105K in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.